Investigação da apoptose plaquetária induzida por heme e pela hemozoína na malária vivax
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
Malaria is a disease caused by the Plasmodium parasite that is transmitted by the
Anopheles mosquito. Although most cases of malaria in the world are caused by P.
falciparum, in Brazil most reports are due to infections by P. vivax. Vivax malaria has
long been neglected as it was considered a benign infection, but severe forms and
complications of the disease, including a sudden drop in platelet count, have been
reported. One of the hypotheses to explain thrombocytopenia is platelet apoptosis,
which may be induced by stimuli released during infection. To understand whether
factors released during vivax malaria were inducing platelet apoptosis, platelets from
healthy donors were incubated with plasma from patients infected with P. vivax. It
was observed that patient plasma induced the apoptotic phenotype in platelets,
evidenced by phosphatidylserine exposure, inner mitochondrial membrane
depolarization, and cell shrinkage. It has been shown that heme and hemozoin, two
toxins released after the lysis of infected red blood cells, induce apoptosis in
trophoblast cells and astrocytes. However, heme- and hemozoin-induced platelet
apoptosis has not yet been described. To investigate this, platelets from healthy
volunteers were incubated with heme or synthetic hemozoin (sHz) and it was
observed that both heme and sHz induced platelet apoptosis. Since the antagonistic
balance between pro and anti-apoptotic proteins regulates apoptosis and the
degradation of Bcl-xL in response to heme was recently evidenced by our group, we
investigated which protein degradation pathway, proteasome or calpains, would be
involved in this process. Platelets from healthy donors were then pretreated with the
proteasome inhibitor, Bortezomib, or the calcium chelator, Bapta-AM, prior to
stimulation with heme and sHz. We observed that treatment with Bortezomib or
Bapta-AM was not able to prevent platelet apoptosis induced by heme and sHz.
Finally, the addition of hemopexin, a heme chelator, reversed the apoptotic effect of
plasma from vivax malaria patients on platelets, suggesting the involvement of heme
in platelet apoptosis. Our results therefore indicate that heme and hemozoin toxins,
through the induction of platelet apoptosis, may be contributing to the
thrombocytopenia observed in vivax malaria.
Description
Keywords
Citation
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

